What is the Smallest Worthwhile Difference in Cardiovascular Risk?

By Peter A. McCullough, MD, MPH Despite dozens of high quality trials, mechanistic studies, and widespread generic availability, there remains great resistance to oral statins to reduce the risk of athersclerotic cardiovascular risk (myocardial infarction, stroke, need for revascularization, and cardiovascular death). Alter AI assisted with this interesting paper from Japan. The study “Measuring Public […]